Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man
- 1 November 1978
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 16 (5) , 651-660
- https://doi.org/10.1016/0090-6980(78)90001-1
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Circulatory and anti-platelet effects of intravenous prostacyclin in healthy menPharmacological Research Communications, 1978
- Prostacyclin is a circulating hormoneNature, 1978
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- COMPARISON OF THE VASODEPRESSOR EFFECTS OF PROSTACYCLIN AND 6‐OXO‐PROSTAGLANDIN F1α WITH THOSE OF PROSTAGLANDIN E2 IN RATS AND RABBITSBritish Journal of Pharmacology, 1978
- Aspects of Prostaglandin Function in the LungNew England Journal of Medicine, 1977
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- Bronchial Reactivity to Prostaglandins F2α, E2, and Histamine in Different Types of AsthmaRespiration, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lungNature, 1976